MEDICO REMEDIES
|
MEDICO REMEDIES Last 5 Year Financial Ratios History
[Standalone]
| Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 0.87 | 2.90 | 6.24 | 3.93 | 3.78 |
| CEPS(Rs) | 1.20 | 0.85 | 0.51 | 0.40 | 0.37 |
| DPS(Rs) | - | - | - | - | - |
| Book NAV/Share(Rs) | 5.28 | 22.04 | 78.22 | 71.98 | 68.05 |
| Tax Rate(%) | 28.29 | 25.78 | 30.00 | 26.40 | 27.81 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 6.75 | 6.06 | 4.28 | 3.21 | 2.83 |
| EBIT Margin(%) | 7.72 | 5.90 | 3.77 | 3.69 | 3.23 |
| Pre Tax Margin(%) | 7.19 | 5.36 | 3.02 | 2.50 | 2.23 |
| PAT Margin (%) | 5.16 | 3.98 | 2.12 | 1.84 | 1.61 |
| Cash Profit Margin (%) | 7.09 | 5.81 | 3.46 | 3.72 | 3.15 |
| Performance Ratios | |||||
| ROA(%) | 8.63 | 6.24 | 3.43 | 2.15 | 2.31 |
| ROE(%) | 18.01 | 13.94 | 8.31 | 5.61 | 5.72 |
| ROCE(%) | 21.88 | 15.09 | 10.13 | 7.66 | 7.79 |
| Asset Turnover(x) | 1.67 | 1.57 | 1.62 | 1.17 | 1.44 |
| Sales/Fixed Asset(x) | 3.91 | 3.95 | 4.60 | 3.79 | 5.17 |
| Working Capital/Sales(x) | 6.10 | 6.23 | 5.96 | 5.48 | 7.11 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.26 | 0.25 | 0.22 | 0.26 | 0.19 |
| Receivable days | 86.40 | 87.18 | 76.51 | 109.06 | 86.09 |
| Inventory Days | 49.13 | 49.25 | 48.92 | 70.69 | 57.88 |
| Payable days | 120.01 | 135.32 | 119.00 | 187.40 | 134.71 |
| Valuation Parameters | |||||
| PER(x) | 85.61 | 5.79 | 0.80 | 0.93 | 1.12 |
| PCE(x) | 62.23 | 19.83 | 9.79 | 9.23 | 11.44 |
| Price/Book(x) | 14.14 | 3.81 | 1.28 | 1.02 | 1.25 |
| Yield(%) | - | - | - | - | - |
| EV/Net Sales(x) | 4.46 | 1.22 | 0.44 | 0.48 | 0.49 |
| EV/Core EBITDA(x) | 46.13 | 15.77 | 8.57 | 8.68 | 10.33 |
| EV/EBIT(x) | 57.70 | 20.67 | 11.63 | 13.09 | 15.28 |
| EV/CE(x) | 7.03 | 1.88 | 0.71 | 0.57 | 0.63 |
| M Cap / Sales | 4.41 | 1.15 | 0.34 | 0.34 | 0.36 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 16.04 | -1.12 | 38.08 | -9.27 | 60.08 |
| Core EBITDA Growth(%) | 44.89 | 49.34 | 26.98 | 5.85 | 6.16 |
| EBIT Growth(%) | 51.79 | 54.66 | 41.11 | 3.85 | -6.98 |
| PAT Growth(%) | 50.49 | 85.79 | 58.86 | 3.84 | 28.68 |
| EPS Growth(%) | -69.90 | -53.54 | 58.83 | 3.84 | 28.68 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.18 | 0.29 | 0.46 | 0.46 | 0.48 |
| Current Ratio(x) | 1.53 | 1.49 | 1.54 | 1.40 | 1.30 |
| Quick Ratio(x) | 1.08 | 1.03 | 1.16 | 0.95 | 0.95 |
| Interest Cover(x) | 14.52 | 10.79 | 5.02 | 3.09 | 3.22 |
| Total Debt/Mcap(x) | 0.01 | 0.08 | 0.36 | 0.46 | 0.38 |
Compare Financial Ratios of peers of MEDICO REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MEDICO REMEDIES | ₹381.8 Cr | -1.2% | -5.6% | -46.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹361,916.0 Cr | 0.3% | -7.5% | 53.9% | Stock Analytics | |
| CIPLA | ₹115,034.0 Cr | 1.1% | -4.8% | 56.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,929.0 Cr | 1.6% | 1.6% | 27.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹104,873.0 Cr | -1.9% | 10.7% | 21.4% | Stock Analytics | |
| ZYDUS LIFESCIENCES | ₹100,322.0 Cr | 5.2% | -0.2% | 90.1% | Stock Analytics | |
MEDICO REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MEDICO REMEDIES | -1.2% |
-5.6% |
-46.2% |
| SENSEX | -0.6% |
0.3% |
21.8% |
You may also like the below Video Courses
